Volume 5 (2021), Issue 3
Complete issue
Editorial
Editorial
Page 107 - 109
Articles
Reconsidering Repositioning Incentives: An Empirical Legal Analysis of Market Protection for New Therapeutic Indications
Page 110 - 122
Medicinal Products and the Screening of Foreign Direct Investment
Questionable Protection of National Security Interests by Tightening Investment Control Law
Page 123 - 128
Reports
New Clinical Trial Rules in the EU: A Practical Overview of the Upcoming Regulation
Page 129 - 137
The Interpretation in France of Causation in Tort Liability Litigations Involving Medical Matters
Page 138 - 145
Pharmacovigilance: Historical Evolution, Legal Frame and Function During the Covid Era
Page 146 - 149
Jurisdiction
Jurisdiction
Page 150 - 151
Legislation
New EU Pharmaceutical Law and Policy
Page 152